Kakar SS

No ORCID on file · 8 papers in corpus · active 2003-2026

Study types

  • other 2

Condition tags

  • endometriosis 1
  • infertility 1
  • adenomyosis 1
2026
Journal of ovarian research ·doi:10.1186/s13048-026-01979-1

Ovarian cancer remains a highly lethal malignancy, with advanced-stage diagnosis, recurrence, and chemoresistance, thus limiting clinical outcomes. Traditional biomarkers such as CA-125, BRCA1/2 status, and histopathology offer only a parti…

2025
Journal of ovarian research ·doi:10.1186/s13048-025-01636-z

Ovarian Cancer (OC) is recognized as the most lethal gynecologic malignancy, characterized by numerous genetic mutations that trigger uncontrolled cellular growth and replication. Emerging evidence suggests that non-coding RNAs including mi…

2022
Cells ·doi:10.3390/cells11060990

Tumor-derived cachectic factors such as proinflammatory cytokines and neuromodulators not only affect skeletal muscle but also affect other organs, including the heart, in the form of cardiac muscle atrophy, fibrosis, and eventual cardiac d…

2021
Cells ·doi:10.3390/cells10071613

Infertility creates an immense impact on the psychosocial wellbeing of affected couples, leading to poor quality of life. Infertility is now considered to be a global health issue affecting approximately 15% of couples worldwide. It may ari…

2017
Stem cells and development ·doi:10.1089/scd.2017.0153

Ovarian cancer is most lethal among gynecological cancers with often fatal consequences due to lack of effective biomarkers and relapse, which propels ovarian cancer research into unique directions to establish solid targeted therapeutics. …

other 2012
BMC cancer ·doi:10.1186/1471-2407-12-532

BACKGROUND: Pituitary tumor-transforming gene (PTTG) is an oncogene that is overexpressed in variety of tumors and exhibits characteristics of a transforming gene. Previous transgenic mouse models to access the tumorigenic potential in the …

2011
PloS one ·doi:10.1371/journal.pone.0019963

In this study, we characterized the metabolome of the human ovary and identified metabolic alternations that coincide with primary epithelial ovarian cancer (EOC) and metastatic tumors resulting from primary ovarian cancer (MOC) using three…

other 2003
Gene ·doi:10.1016/s0378-1119(03)00446-3

Gonadotropin-releasing hormone (GnRH) is a neuropeptide that plays a pivotal role in reproductive processes. In recent years, it has become clear that it is also an anti-proliferative agent. GnRH analogs are now used clinically in the treat…